Genevide Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $6.15M

  • Investors
  • 4

Genevide General Information

Description

Developer of a molecular enzyme cycle screening platform intended to solve the problem of sinking nucleic acid detection. The company offers enzyme-mediated one-step sample processing technology (EmOSP) and enzyme-mediated double exponential amplification nucleic acid detection technology (EmDEA), providing researchers with resources to make nucleic acid detection within reach.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Unit 101B, Building 20, Zone B, Phase II, Biomedicine Industrial Park
  • No. 218, Sangtian Street, Suzhou Industrial Park
  • Suzhou, Jiangsu
  • China
+86 0512
Primary Industry
Discovery Tools (Healthcare)
Vertical(s)
Corporate Office
  • Unit 101B, Building 20, Zone B, Phase II, Biomedicine Industrial Park
  • No. 218, Sangtian Street, Suzhou Industrial Park
  • Suzhou, Jiangsu
  • China
+86 0512

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genevide Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 09-Sep-2021 $6.15M Completed Generating Revenue
To view Genevide’s complete valuation and funding history, request access »

Genevide Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Qiming Venture Partners Venture Capital Minority
YuanBio Venture Capital Venture Capital Minority
Ascendin Fund Corporate Venture Capital Minority
Tri River Capital Venture Capital Minority
To view Genevide’s complete investors history, request access »

Genevide Acquisitions (1)

Genevide’s most recent deal was a Merger/Acquisition with Clickgene. The deal was made on 22-Jul-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Clickgene 22-Jul-2021 Merger/Acquisition Biotechnology
To view Genevide’s complete acquisitions history, request access »

Genevide Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Clickgene Suzhou, China 2015

Genevide FAQs

  • When was Genevide founded?

    Genevide was founded in 2021.

  • Where is Genevide headquartered?

    Genevide is headquartered in Suzhou, China.

  • What industry is Genevide in?

    Genevide’s primary industry is Discovery Tools (Healthcare).

  • Is Genevide a private or public company?

    Genevide is a Private company.

  • What is Genevide’s current revenue?

    The current revenue for Genevide is .

  • How much funding has Genevide raised over time?

    Genevide has raised $6.15M.

  • Who are Genevide’s investors?

    Qiming Venture Partners, YuanBio Venture Capital, Ascendin Fund, and Tri River Capital have invested in Genevide.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process